Complement and humoral immunity

Vaccine

Volumn 26, Issue SUPPL. 8, 2008, Pages

  Carroll, Michael C ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Complement receptors; Humoral immunity; Innate immunity

Indexed keywords

ANTIGEN; B LYMPHOCYTE RECEPTOR; CD19 ANTIGEN; CD81 ANTIGEN; COMPLEMENT; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3B RECEPTOR; COMPLEMENT COMPONENT C3D; COMPLEMENT COMPONENT C3D RECEPTOR; COMPLEMENT COMPONENT C4;

ADAPTIVE IMMUNITY; ANTIBODY PRODUCTION; B LYMPHOCYTE; B LYMPHOCYTE DIFFERENTIATION; COMPLEMENT SYSTEM; EFFECTOR CELL; FOLLICULAR DENDRITIC CELL; HOST PATHOGEN INTERACTION; HUMORAL IMMUNITY; IMMUNE RESPONSE; INNATE IMMUNITY; MEMORY CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; ANTIBODY FORMATION; B-LYMPHOCYTES; CELL DIFFERENTIATION; COMPLEMENT C3D; COMPLEMENT SYSTEM PROTEINS; HUMANS; RECEPTORS, COMPLEMENT 3B; RECEPTORS, COMPLEMENT 3D;

EID: 57649237605     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.11.022     Document Type: Review

References (52)

1. Bordet J., and Gengou O. Sur l'existence de substances sensibilisatrices dans la plupart des serum antimicrobiens. Annal Inst Pasteur 15 (1901) 289-302
2. Reid K.B.M., and Porter R.R. The proteolytic activation systems of complement. Annu Rev Biochem 50 (1981) 433-464
3. Nussenzweig V., Bianco C., Dukor P., and Eden A. Receptors for C3 on B lymphocytes: possible role in the immune response (1971), Academic Press, New York
4. Pepys M.B. Role of complement in induction of the allergic response. Nature: New Biology 237 (1972) 157-159
5. Jackson C.G., Ochs H.D., and Wedgewood R.J. Immune response of a patient with deficiency of the fourth component of complement and systemic lupus erythematosus. N Engl J Med 300 (1979) 1124-1129
6. Bottger E.C., Metzger S., Bitter-Suermann D., Stevenson G., Kleindienst S., and Burger R. Impaired humoral immune response in complement C3-deficient guinea pigs: absence of secondary antibody response. Eur J Immunol 16 (1986) 1231-1235
7. Ochs H.D., Wedgwood R.J., Frank M.M., Heller S.R., and Hosea S.W. The role of complement in the induction of antibody responses. Clin Exp Immunol 53 (1983) 208-216
8. O'Neil K.M., Ochs H.D., Heller S.R., Cork L.C., Morris J.M., and Winkelstein J.A. Role of C3 in humoral immunity: defective antibody production in C3-deficient dogs. J Immunol 140 (1988) 1939-1945
9. Finco O., Li S., Cuccia M.-C., Rosen F.S., and Carroll M.C. Structural differences between the two human complement C4 isotypes affects the humoral immune response. J Exp Med 175 (1992) 537-543
10. Carter R.H., and Fearon D.T. CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes. Science (New York, NY) 256 5053 (1992) 105-107
11. Law S.K., and Levine R.P. Interaction between the third complement protein and cell surface macromolecules. Proc Natl Acad Sci USA 74 (1977) 2701-2705
12. Isenman D.E., and Young J.R. The molecular basis for the difference in immune hemolysis activity of the Chido and Rodgers isotypes of human complement component C4. J Immunol 132 6 (1984) 3019-3027
13. Tack B.F., Harrison R.A., Janatova J., Thomas M.L., and Prahl J.W. Evidence for presence of an internal thiolester bond in third component of human complement. Proc Natl Acad Sci USA 77 (1980) 5764-5768
14. Helmy K.Y., Katschke Jr. K.J., Gorgani N.N., Kljavin N.M., Elliott J.M., Diehl L., et al. CRIg: a macrophage complement receptor required for phagocytosis of circulating pathogens. Cell 124 5 (2006) 915-927
15. Xu C., Mao D., Holers V.M., Palanca B., Cheng A.M., and Molina H. A critical role for murine complement regulator crry in fetomaternal tolerance. Science (New York, NY) 287 (2000) 498-501
16. Kinoshita T., Lavoie S., and Nussenzweig V. Regulatory proteins for the activated third and fourth components of complement (C3b and C4b) in mice. II. Identification and properties of complement receptor 1 (CR1). J Immunol 134 (1985) 2564
17. Kinoshita T., Thyphronitis G., Tsokos C.G., Finkelman F.D., Hong K., Sakai H., et al. Characterization of murine complement receptor type 2 and its immunological cross-reactivity with type 1 receptor. Int Immunol 2 (1990) 651
18. Ahearn J.M., and Fearon D.T. Structure and function of the complement receptors, CR1 (CD35) and CR2 (CD21). Adv Immunol 46 (1989) 183-219
19. Kurtz C.B., O'Toole E., Christensen S.M., and Weis J.H. The murine complement receptor gene family. IV. Alternative splicing of Cr2 gene transcripts predicts two distinct gene products that share homologous domains with both human CR2 and CR1. J Immunol 144 (1990) 3581-3591
20. Rajewsky K. Clonal selection and learning in the antibody system. Nature 381 6585 (1996) 751-758
21. Carroll M.C. The complement system in regulation of adaptive immunity. Nat Immunol 5 10 (2004) 981-986
22. Guinamard R., Okigaki M., Schlessinger J., and Ravetch J.V. Absence of marginal zone B cells in Pyk-2-deficient mice defines their role in the humoral response. Nat Immunol 1 1 (2000) 31-36
23. Pozdnyakova O., Guttormsen H.K., Lalani F.N., Carroll M.C., and Kasper D.L. Impaired antibody response to group B streptococcal type III capsular polysaccharide in C3- and complement receptor 2-deficient mice. J Immunol 170 1 (2003) 84-90
24. Ochsenbien A., Pinschewer D., Odermatt B., Carroll M., Hengartner H., and Zinkernagel R. Protective T cell-independent antiviral antibody responses are dependent on complement. J Exp Med 190 (1999) 1165-1174
25. Fischer M., Ma M., Goerg S., Zhou X., Xia J., Finco O., et al. Regulation of the B cell response to T-dependent antigens by classical pathway complement. J Immunol 157 (1996) 549-556
26. Ahearn J., Fischer M., Croix D., Goerg S., Ma M., Xia J., et al. Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen. Immunity 4 (1996) 251-262
27. Molina H., Holers V.M., Li B., Fung Y., Mariathasan S., Goellner J., et al. Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2. Proc Natl Acad Sci USA 93 8 (1996) 3357-3361
28. Typhronitis G., Kinoshita T., Inoue K., Schweinle J.E., Tsokos G.C., Metcalf E.S., et al. Modulation of mouse complement receptors 1 and 2 suppresses antibody responses in vivo. J Immunol 147 (1991) 224-230
29. Gustavsson S., Kinoshita T., and Heyman B. Antibodies to murine complement receptor 1 and 2 can inhibit the antibody response in vivo without inhibiting T helper cell induction. J Immunol 154 (1995) 6524-6528
30. DaCosta X., Brockman M., Alicot E., Ma M., Fischer M.B., Zhou X., et al. Humoral response to herpes simplex virus is complement dependent. Proc Natl Acad Sci USA 96 (1999) 12708
31. Verschoor A., Brockman M.A., Knipe D.M., and Carroll M.C. Cutting edge: myeloid complement C3 enhances the humoral response to peripheral viral infection. J Immunol 167 5 (2001) 2446-2451
32. Mehlhop E., and Diamond M.S. Protective immune responses against West Nile virus are primed by distinct complement activation pathways. J Exp Med 203 5 (2006) 1371-1381
33. Haas K.M., Hasegawa M., Steeber D.A., Poe J.C., Zabel M.D., Bock C.B., et al. Complement receptors CD21/35 link innate and protective immunity during Streptococcus pneumoniae infection by regulating IgG3 antibody responses. Immunity 17 6 (2002) 713-723
34. Barrington R.A., Pozdnyakova O., Zafari M.R., Benjamin C.D., and Carroll M.C. B lymphocyte memory: role of stromal cell complement and FcgammaRIIB receptors. J Exp Med 196 9 (2002) 1189-1199
35. Wang Y., Huang G., Wang J., Molina H., Chaplin D.D., and Fu Y.X. Antigen persistence is required for somatic mutation and affinity maturation of immunoglobulin. Eur J Immunol 30 8 (2000) 2226-2234
36. Bradbury L.E., Kansas G.S., Levy S., Evans R.L., and Tedder T.T. The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules. J Immunol 149 (1992) 2841
37. Carter R.H., and Fearon D.T. CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes. Science (New York, NY) 256 (1992) 105-107
38. Fearon D.T., and Locksley R.M. The instructive role of innate immunity in the acquired immune response. Science (New York, NY) 272 (1996) 50-54
39. Dempsey P.W., Allison M.E., Akkaraju S., Goodnow C.C., and Fearon D.T. C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science (New York, NY 271 5247 (1996) 348-350
40. Barrington R.A., Zhang M., Zhong X., Jonsson H., Holodick N., Cherukuri A., et al. CD21/CD19 coreceptor signaling promotes B cell survival during primary immune responses. J Immunol 175 5 (2005) 2859-2867
41. Fischer M.B., Goerg S., Shen L., Prodeus A.P., Goodnow C.C., Kelsoe G., et al. Dependence of germinal center B cells on expression of CD21/CD35 for survival. Science (New York, NY) 280 5363 (1998) 582-585
42. Brockman M.A., Verschoor A., Zhu J., Carroll M.C., and Knipe D.M. Optimal long-term humoral responses to replication-defective herpes simplex virus require CD21/CD35 complement receptor expression on stromal cells. J Virol 80 14 (2006) 7111-7117
43. Ferguson A.R., Youd M.E., and Corley R.B. Marginal zone B cells transport and deposit IgM-containing immune complexes onto follicular dendritic cells. Int Immunol 16 10 (2004) 1411-1422
44. Cinamon G., Zachariah M.A., Lam O.M., Foss Jr. F.W., and Cyster J.G. Follicular shuttling of marginal zone B cells facilitates antigen transport. Nat Immunol 9 1 (2008) 54-62
45. Junt T., Moseman E.A., Iannacone M., Massberg S., Lang P.A., Boes M., et al. Subcapsular sinus macrophages in lymph nodes clear lymph-borne viruses and present them to antiviral B cells. Nature 450 7166 (2007) 110-114
46. Carrasco Y.R., and Batista F.D. B cells acquire particulate antigen in a macrophage-rich area at the boundary between the follicle and the subcapsular sinus of the lymph node. Immunity 27 1 (2007) 160-171
47. Phan T.G., Grigorova I., Okada T., and Cyster J.G. Subcapsular encounter and complement-dependent transport of immune complexes by lymph node B cells. Nat Immunol 8 9 (2007) 992-1000
48. Pape K.A., Catron D.M., Itano A.A., and Jenkins M.K. The humoral immune response is initiated in lymph nodes by B cells that acquire soluble antigen directly in the follicles. Immunity 26 4 (2007) 491-502
49. Roozendaal R, Mempel T, Pitcher L, et al. Conduits mediate transport of antigen to lymph node follicles. Immunity; in press.
50. Gretz J.E., Norbury C.C., Anderson A.O., Proudfoot A.E., and Shaw S. Lymph-borne chemokines and other low molecular weight molecules reach high endothelial venules via specialized conduits while a functional barrier limits access to the lymphocyte microenvironments in lymph node cortex. J Exp Med 192 10 (2000) 1425-1440
51. Sixt M., Kanazawa N., Selg M., Samson T., Roos G., Reinhardt D.P., et al. The conduit system transports soluble antigens from the afferent lymph to resident dendritic cells in the T cell area of the lymph node. Immunity 22 1 (2005) 19-29
52. Mempel T.R., Junt T., and von Andrian U.H. Rulers over randomness: stroma cells guide lymphocyte migration in lymph nodes. Immunity 25 6 (2006) 867-869